Chemical Compound
N-[4-[(4,5-Dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-[1,1'-biphenyl]-2-carboxamide Hydrochloride (1:1); [1,1'-Biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-, monohydrochloride (9CI); Conivaptan hydrochloride; Vaprisol; YM 087; conivaptan monohydrochloride
CAS Registry Number
168626-94-6
Primary record
N-[4-[(4,5-Dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-[1,1'-biphenyl]-2-carboxamide Hydrochloride (1:1); [1,1'-Biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-, monohydrochloride (9CI); Conivaptan hydrochloride; Vaprisol; YM 087; conivaptan monohydrochloride
- 库存
- 9,675 克
- 纯度
- 98.9 %
- CAS
- 168626-94-6
化合物标识与属性
- CAS
- 168626-94-6
- PubChem CID
- 216322
- SMILES
- CC1=NC2=C(N1)CCN(C3=CC=CC=C32)C(=O)C4=CC=C(C=C4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6.Cl
- Canonical SMILES
- Cc1nc2c([nH]1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1-2.Cl
名称与同义词
- Conivaptan hydrochloride
- Conivaptan HCl
- Vaprisol
- 168626-94-6
- Vapriso l
- Vaprisol (TN)
- vaprisol hydrochloride
- Conivaptan (hydrochloride)
- Conivaptan HCl (Vaprisol)
- RefChem:56751
- Conivaptan hydrochloride [USAN]
- Conivaptan hydrochloride?
- MFCD00945712
- YM 087
- AC1Q3DXX
- C32H27ClN4O2
- CI-1025
- YM087
- UNII-75L57R6X36
- CHEBI:31430
- MLS006010030
- MLS006010233
- C32H20N4O2.ClH
- SCHEMBL387232
- DTXSID70168585
- CONIVAPTAN HCL [VANDF]
- YM-087
- AC1L50I9
- orb1300756
- 75L57R6X36
- CHEMBL1201108
- DTXCID9091076
- SCHEMBL28043077
- EBD4965
- BTYHAFSDANBVMJ-UHFFFAOYSA-N
- s2116
- Vaprisol, Conivaptan hydrochloride
- GLXC-08122
- HMS5080M12
- HY-18347AR
- BCP28426
- EX-A1128
- KS-00000QO3
- C32-H20-N4-O2.Cl-H
- AN-986
- AR-1K4737
- CID216322
- Conivaptan hydrochloride (JAN/USAN)
- CONIVAPTAN HYDROCHLORIDE [MI]
- HY-18347A
- MFCD11046542
- CONIVAPTAN HYDROCHLORIDE [JAN]
- AKOS015994583
- AKOS025401635
- Conivaptan (hydrochloride) (Standard)
- ACN-057387
- CCG-269940
- CS-2015
- CS-O-10463
- EBC-101094
- FC20552
- FE-0225
- MP-1696
- CONIVAPTAN HYDROCHLORIDE [MART.]
- CONIVAPTAN HYDROCHLORIDE [WHO-DD]
- AC-23918
- AK104672
- BC677679
- LS-44227
- SMR004701209
- SY105554
- AB2000519
- DB-064699
- A8402
- AM20090724
- FT-0657174
- ST24024699
- SW219215-1
- Y0319
- CONIVAPTAN HYDROCHLORIDE [ORANGE BOOK]
- N-(4-(2-methyl-1,4,5,6-tetrahydrobenzo[b]imidazo[4,5-d]azepine-6-carbonyl)phenyl)-[1,1'-biphenyl]-2-carboxamide hydrochloride
- N-[4-(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamide hydrochloride
- D01236
- 8626-94-6
- 626C946
- A810997
- [1,1'-Biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-, hydrochloride (1:1)
- VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER
- Q27114306
- (1,1'-Biphenyl)-2-carboxamide, N-(4-((4,5-dihydro-2-methylimidazo(4,5-d)(1)benzazepin-6(1H)-yl)carbonyl)phenyl)-, monohydrochloride
- N-[4-(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamide;hydrochloride
- B2693-060667
- 4'-((4,5-Dihydro-2-methylimidazo(4,5-d)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide monohydrochloride
- N-[4-({4-methyl-3,5,9-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(14),2(6),4,10,12-pentaen-9-yl}carbonyl)phenyl]-2-phenylbenzamide hydrochloride
- N-[4-[(4,5-Dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-[1,1'-Biphenyl]-2-carboxamide Hydrochloride
- 4'-[(2-Methyl-1,4,5,6-tetrahydroimidazo[4,5-d][1]benzazepin-6-yl)-carbonyl]-2-phenylbenzanilide monohydrochloride
- n-{4-[(2-methyl-4,5-dihydroimidazo[4,5-d][1]benzazepin-6(1h)-yl)carbonyl]phenyl}biphenyl-2-carboxamidhydrochlorid
- (1,1'-Biphenyl)-2-carboxamide,N-(4-((4,5-dihydro-2-methylimidazo(4,5-d)(1)benzazepin-6(1H)-yl)carbonyl)phenyl)-,monohydrochloride
- [1,1'-Biphenyl]-2-carboxamide,N-[4-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-,hydrochloride (1:1)
- 2725-81-7
- 4''-((4,5-DIHYDRO-2-METHYLIMIDAZO(4,5-D)(1)BENZAZEPIN-6(1H)-YL)CARBONYL)-2-BIPHENYLCARBOXANILIDE MONOHYDROCHLORIDE
- 4'-[(2-methyl-1,4,5,6-tetrahydroimidazo[4,5-d][1]benzazepin-6-yl)carbonyl]-2-phenylbenzanilide hydrochloride
- N-(4-(2-methyl-1,4,5,6-tetrahydrobenzo[b]imidazo[4,5-d]azepine-6-carbonyl)phenyl)-[1,1'-biphenyl]-2-carboxamidehydrochloride
- N-(4-{4-methyl-3,5,9-triazatricyclo[8.4.0.0(2),?]tetradeca-1(10),2(6),3,11,13-pentaene-9-carbonyl}phenyl)-[1,1'-biphenyl]-2-carboxamide hydrochloride
- N-[4-(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenyl-benzamide hydrochloride
- N-[4-(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenyl-benzamide;hydrochloride
- N-[4-(2-Methyl-4,5-dihydroimidazo[4,5-d][1]benzazepine-6(3H)-carbonyl)phenyl][1,1'-biphenyl]-2-carboxamide--hydrogen chloride (1/1)
- N-[4-[(4,5-Dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-[1,1'-biphenyl]-2-carboxamide Hydrochloride (1:1); [1,1'-Biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-, monohydrochloride (9CI); Conivaptan hydrochloride; Vaprisol; YM 087; conivaptan monohydrochloride
- N-[4-[(4,5-Dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-[1,1?-Biphenyl]-2-carboxamide Hydrochloride
- N-{4-[(2-methyl-4,5-dihydroimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl}biphenyl-2-carboxamide hydrochloride